Benefit of anti-hepatitis B immunoglobulin( HBIG) monotherapy compared to HBIG combined with entecavir in long term renal function

被引：0
|
作者：
Choi, M. [1 ]
Lee, J. G. [1 ]
Jung, Y. B. [1 ]
Kim, S., I [1 ]
Ju, M. K. [1 ]
Lee, J. [2 ]
Kim, H. [2 ]
机构：
[1] Yonsei Univ, Coll Med, Seoul, South Korea
[2] Severance Hosp, Seoul, South Korea
来源：
TRANSPLANTATION | 2018年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
LB P-033
引用
收藏
页码：314 / 314
页数：1
相关论文
共 50 条
  • [21] Lamivudine without HBIg for prevention of graft infection by hepatitis B; Long-term follow-up.
    Mutimer, DJ
    Grellier, L
    Barrett, CA
    Ahmed, M
    Burroughs, AK
    Anschuetz, GC
    Dusheiko, GM
    Elias, EA
    HEPATOLOGY, 1999, 30 (04) : 301A - 301A
  • [22] Prophylactic hepatitis B immunoglobulin (HBIg) in liver transplant (OLT) recipients: Anti-HBs titers on a fixed dosing schedule
    Terrault, NA
    Hahn, JA
    Lake, JR
    Roberts, JP
    Ascher, NL
    Wright, TL
    GASTROENTEROLOGY, 1996, 110 (04) : A1344 - A1344
  • [23] Substitution of lamivudine for long-term HBIG after liver transplantation for hepatitis B related liver disease.
    Dobson, SF
    Balan, V
    Shakil, O
    Bonham, A
    Rakela, J
    Fung, JJ
    HEPATOLOGY, 1998, 28 (04) : 262A - 262A
  • [24] Risk factors for de novo hepatitis B virus reactivation in liver transplant recipient with long term HBIG treatment
    Umeda, Makoto
    Marusawa, Hiroyuki
    Ueda, Mikiko
    Tanaka, Yuichi
    Takada, Yasutsugu
    Egawa, Hiroto
    Uemoto, Shinji
    Chiba, Tsutomu
    GASTROENTEROLOGY, 2006, 130 (04) : A787 - A787
  • [25] Renal Tubular Dysfunction of Prophylactic Treatment With Anti-Hepatitis B Immunoglobulin Combined Lamivudine and Adefovir Dipivoxil in Liver Recipients
    Lee, Jae Geun
    Lee, Juhan
    Lee, Jung Jun
    Ju, Man Ki
    Choi, Gi Hong
    Kim, Myoung Soo
    Choi, Jin Sub
    Kim, Soon Il
    Joo, Dong Jin
    TRANSPLANTATION, 2015, 99 : 272 - 272
  • [26] Long-term impact of entecavir monotherapy in chronic hepatitis B patients with a partial virologic response to entecavir therapy
    Ko, Soon Young
    Choe, Won Hyeok
    Kwon, So Young
    Kim, Jeong Han
    Seo, Jung Woong
    Kim, Kyun-Hwan
    Lee, Chang Hong
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2012, 47 (11) : 1362 - 1367
  • [27] Long-term Outcome of Entecavir Monotherapy after Liver Transplantation for Chronic Hepatitis B
    Fung, James
    Wong, Tiffany C.
    Cheung, Cindy K.
    Chok, Kenneth S.
    Dai, Wing-chiu
    Cheung, Tan To
    Sharr, William
    Chan, Albert
    Sin, Sui-Ling
    Chan, See-Ching
    Lai, Ching-Lung
    Yuen, Man-Fung
    Lo, Chung-Mau
    HEPATOLOGY, 2015, 62 : 1059A - 1060A
  • [28] Long-Term Outcomes of Prophylaxis with Entecavir and Hepatitis B Immunoglobulin After Liver Transplantation for Hepatitis B Virus
    Togashi, Junichi
    Akamatsu, Nobuhisa
    Sugawara, Yasuhiko
    Tamura, Sumihito
    Kaneko, Junichi
    Arita, Junichi
    Sakamoto, Yoshihiro
    Hasegawa, Kiyoshi
    Kokudo, Norihiro
    TRANSPLANTATION, 2016, 100 : S181 - S181
  • [29] QUANTITATIVE ANTI-HBS TITERS DURING INTRAMUSCULAR (IM) HEPATITIS-B IMMUNOGLOBULIN (HBIG) ADMINISTRATION POST LIVER-TRANSPLANTATION (LT) FOR HEPATITIS-B
    VILLAMIL, F
    KUHNS, M
    MAKOWKA, L
    PODESTA, L
    HOWARD, T
    SHER, L
    MEMSIC, L
    HOFFMAN, A
    VIERLING, J
    HEPATOLOGY, 1992, 16 (04) : A49 - A49
  • [30] Impact of long-term antiviral therapy with Entecavir on renal function in elderly patients with chronic hepatitis B
    梁丽
    China Medical Abstracts(Internal Medicine), 2020, 37 (01) : 16 - 16
12345